Suscribirse

Impact of an ultrasound-guided radiofrequency ablation training program on the outcomes in patients with hepatocellular carcinoma - 26/11/19

Doi : 10.1016/j.diii.2019.08.004 
R. Takai Takamatsu a, b, A. Okano a, , G. Yamakawa a, K. Mizukoshi a, H. Obayashi c, M. Ohana a
a Department of Gastroenterology, Tenri Hospital, Nara, Japan 
b Third Department of Internal Medicine, Nara Medical University, Nara, Japan 
c Department of Clinical Pathology, Tenri Hospital, Nara, Japan 

Corresponding author. Department of Gastroenterology, Tenri Hospital, 200 Mishima-cho, 632-8552 Tenri, Nara, Japan.Department of Gastroenterology, Tenri Hospital200 Mishima-choTenri, Nara632-8552Japan

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Purpose

The aim of this study was to retrospectively evaluate the impact of a training program on the safety and efficacy of percutaneous ultrasound-guided radiofrequency ablation (RFA) for the treatment of hepatocellular carcinoma (HCC).

Materials and methods

A total of 227 patients with 296 HCC nodules who underwent percutaneous RFA with or without transcatheter arterial chemoembolization at our institution were included. There were 163 men and 64 women with a mean age of 74.2±8.3 (SD) years (range: 41–89 years). Percutaneous ultrasound-guided RFA was performed by three trainees (205 HCC nodules in 157 patients) or a mentor (91 HCC nodules in 70 patients) after preprocedural preparation including planning ultrasonography. We compared background-related, tumor-related, and treatment-related factors, and local recurrence and complication rates between the trainee group and the mentor group. Similarly, we compared these variables among the years 2015, 2016, and 2017 for trainee group.

Results

The proportion of easy-to-treat tumors in the trainee group (109/205; 53.2%) was greater than that in the mentor group (33/91; 36.3%) (P=0.020). No significant differences were observed in procedure difficulty among the years 2015, 2016, and 2017 for trainee group (easy-to-treat HCC nodules: 25/47; 53.2% vs. 39/79; 49.4% vs. 45/79; 57.0%. P=0.775). The local recurrence rate in the trainee group was 8.8% (18/205 HCC nodules) which was equivalent to 7.7% in the mentor group (7/91 HCC nodules). No significant differences were observed in local recurrence rate (8.8% vs. 7.7%, respectively; P=0.621) and major complication rate (1.3% vs. 1.4%, respectively; P=0.999) between the trainee group and the mentor group. No significant differences were observed in local recurrence rates ([5/47; 10.6%] vs. [11/79; 13.9%] vs. [2/79; 2.5%]) (P=0.109) and major complication rates ([1/36; 2.8%] vs. [1/62; 1.6%] vs. [0/59; 0%]) (P=0.701) between the years 2015, 2016, and 2017 for trainee group.

Conclusion

A well supervised training program that includes planning ultrasonography fosters the efficacy and treatment quality of RFA for HCC.

El texto completo de este artículo está disponible en PDF.

Keywords : Radiofrequency ablation, Training program, Hepatocellular carcinoma, Mentors, Education


Esquema


© 2019  Société française de radiologie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 100 - N° 12

P. 771-780 - décembre 2019 Regresar al número
Artículo precedente Artículo precedente
  • Noise assessment across two generations of iterative reconstruction algorithms of three manufacturers using bone reconstruction kernel
  • J. Greffier, J. Frandon, A. Larbi, D. Om, J.P. Beregi, F. Pereira
| Artículo siguiente Artículo siguiente
  • Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation
  • V. Aufranc, G. Farouil, M. Abdel-Rehim, P. Smadja, M. Tardieu, S. Aptel, A. Guibal

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.